CD4 and cervical carcinoma: (Grover et al., 2018, MacDuffie et al., 2021) The authors attributed this finding to the well-controlled HIV disease in their study population with a relatively high median CD4 cell count at cervical cancer diagnosis (481 cells/μL) and virtually all HIV-positive patients (96 %) receiving ART.